Trial Profile

DFN-11 Injection in Episodic Migraine With or Without Aura

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sumatriptan (Primary)
Indications Migraine
Focus Therapeutic Use
Acronyms RESTOR
Sponsors Dr Reddys Laboratories

Most Recent Events

23 Jul 2018 Status changed from active, no longer recruiting to completed.
01 Jul 2018 Results assessing the safety of Sumatriptan Injection with focus on Triptan Sensations and Injection Site Reactions, presented at the 60th Annual Scientific Meeting of the American Headache Society
01 Jul 2018 Results (n=268) presented at the 60th Annual Scientific Meeting of the American Headache Society.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com